Holen Sie sich die Stockscreener-App
244.42
0.34%
-0.7174
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$245.14
Offen:
$243.7
24-Stunden-Volumen:
15,490
Relative Volume:
0.03
Marktkapitalisierung:
$20.44B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
47.46
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
-2.27%
1M Leistung:
+5.31%
6M Leistung:
+9.39%
1J Leistung:
+7.41%
1-Tages-Spanne:
$243.70
$244.73
1-Wochen-Bereich:
$243.59
$254.79
52-Wochen-Spanne:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
244.16 | 20.44B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
537.48 | 208.55B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
197.97 | 144.98B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
139.05 | 40.44B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.51 | 37.97B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
196.47 | 35.38B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Here's Why Labcorp (LH) is a Strong Growth Stock - Yahoo Finance
Are Investors Undervaluing Labcorp (LH) Right Now? - Yahoo Finance
Piper Sandler Adjusts Labcorp Price Target to $260 From $240, Maintains Neutral Rating - Marketscreener.com
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Simply Wall St
Labcorp targets 2025 EPS growth of up to 10% with expanding margins - MSN
Jefferies raises LabCorp stock price target to $290 - MSN
Barclays Adjusts Labcorp Holdings' Price Target to $260 From $271 -February 07, 2025 at 11:59 am EST - Marketscreener.com
Truist Adjusts Price Target on Labcorp Holdings to $285 From $275 -February 07, 2025 at 10:30 am EST - Marketscreener.com
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2024 Earnings Call Transcript - Insider Monkey
Labcorp Reports Strong 2024 Results and 2025 Outlook - TipRanks
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics - MSN
Jefferies raises LabCorp stock price target to $290 By Investing.com - Investing.com Australia
Labcorp's Narrow Economic Moat Remains Solid - Morningstar
Truist Securities Adjusts Labcorp Price Target to $285 From $275, Maintains Buy Rating - Marketscreener.com
Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72 - Yahoo Finance
Labcorp Q4 Earnings & Revenues Beat, Margins Down, Stock Tumbles - MSN
Labcorp Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Labcorp Outperforms Expectations with Strong Q4 2024 ResultsNews and Statistics - IndexBox, Inc.
Labcorp (NYSE:LH) Surprises With Q4 Sales, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Labcorp Holdings Inc Reports Q4 Revenue of $3.33 Billion, Exceeding Estimates; EPS Falls Short at $1.70 - GuruFocus.com
Labcorp (LH) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Labcorp Expects Major Revenue Growth Thanks To Rising Test Demand - Finimize
Labcorp Q4 Adjusted EPS, Revenue Increase -February 06, 2025 at 07:17 am EST - Marketscreener.com
Labcorp: Q4 Earnings Snapshot -February 06, 2025 at 07:18 am EST - Marketscreener.com
Labcorp: Q4 Earnings Snapshot - WRAL News
Labcorp Holdings earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Earnings Flash (LH) Labcorp Holdings Posts Q4 Revenue $3.33B, vs. FactSet Est of $3.31B - Marketscreener.com
Earnings Flash (LH) Labcorp Holdings Posts Q4 Adjusted EPS $3.45, vs. FactSet Est of $3.05 - Marketscreener.com
Labcorp forecasts 2025 revenue above estimates on diagnostic test demand - Yahoo Finance
Labcorp Announces 2024 Fourth Quarter and Full Year Results - PR Newswire
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025 - Finansavisen
Labcorp (LH) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Labcorp (LH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
Beyond The Numbers: 6 Analysts Discuss Labcorp Holdings Stock - Benzinga
Barclays Adjusts Labcorp Price Target to $271 From $249, Maintains Equal Weight Rating - Marketscreener.com
Labcorp Set to Report Q4 Earnings: What's in Store for the Stock? - MSN
Laboratory Corporation of America Holdings Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Labcorp expands credit facility to $700 million By Investing.com - Investing.com Australia
Labcorp expands credit facility to $700 million - Investing.com India
Labcorp Holdings Inc. (LH) Expands Receivables Purchase Agreemen - GuruFocus.com
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Labcorp Can't Flip Patent Board Loss At Fed. Circ. - Law360
Labcorp Maintains Quarterly Cash Dividend at $0.72 a Share; Payable June 8 to Shareholders of Record as of May 18 - Marketscreener.com
Jim Cramer on Labcorp Holdings Inc. (LH): ‘The Problem Is It’s Healthcare And People Do Not Like The Healthcare Stocks’ - Insider Monkey
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.28%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):